Clinical studies recruiting near Calgary

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Prediction of Intraventricular Hemorrhage Using Echocardiography and Near Infrared Spectroscopy
Phase N/A · Foothillls Medical Centre · Mount Sinai Hospital, Canada · NCT05708105 Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Arthur J.E. Child Comprehensive Cancer Centre · Eli Lilly and Company · NCT07218380 Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · University of Calgary - Foothills Medical Centre · Joseph Broderick, MD · NCT07227246 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Prostate Cancer Centre · Pfizer · NCT07028853 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Arthur J E Child Comprehensive Cancer Centre · National Cancer Institute (NCI) · NCT05564390 Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma Wi
Phase 3 · Research Site · AstraZeneca · NCT07509151 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Alberta Children's Hospital · National Cancer Institute (NCI) · NCT06172296 Carotid Intraplaque Neovascularization Combined With Stress Echo
Phase N/A · University of Calgary · Dr. Amer Johri · NCT05416385 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · CaRe Clinic (Calgary) · Boehringer Ingelheim · NCT07355296 Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling
Phase 2 · Alberta Children's Hospital · University of Calgary · NCT03214354 Sleep Quality in Assisted-Living Residents
Phase N/A · University of Calgary · University of Calgary · NCT04400617 UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease
Phase N/A · Alberta Children's Hospital - University of Calgary · The Hospital for Sick Children · NCT06560606 Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · Alberta Children's Hospital · PedAL BCU, LLC · NCT05183035 A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During P
Phase N/A · Metabolics and Genetics in Calgary (MAGIC) · BioMarin Pharmaceutical · NCT05579548 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Alberta Children's Hospital · National Cancer Institute (NCI) · NCT05691478 Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Phase 2 · Alberta Children's Hospital · Giselle Sholler · NCT02559778 A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advance
Phase 1/Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT06885034 Dialectal Behaviour Therapy to Enhance Health Behaviour Change for Adolescents Living With Obesity (DIRECTION Trial)
NA · University of Calgary · University of Manitoba · NCT05338944 LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada
Phase N/A · Research Site · AstraZeneca · NCT07143110 Cerebral Blood Flow and Ventilatory Responses During Sleep in Normoxia and Intermittent Hypoxia
Phase 1/Phase 2 · University of Calgary · University of Calgary · NCT03255408 A Platform Trial for Gram Negative Bloodstream Infections
NA · Foothills Hospital · Sunnybrook Health Sciences Centre · NCT06537609 A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Phase 2 · Beacon Dermatology · Takeda · NCT07244263 Quality of Pediatric Resuscitation in a Multicenter Collaborative
Phase N/A · Alberta Children's · Children's Hospital of Philadelphia · NCT02708134 A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide
Phase 1/Phase 2 · Arthur J E Child Comprehensive Cancer Centre · Celgene · NCT06988488 A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Dia
Phase 3 · Alberta Children's Hospital · Eli Lilly and Company · NCT07222332 A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Phase 3 · MyCliniResearch, Inc. · Eli Lilly and Company · NCT07369011 Selinexor and Backbone Treatments of Multiple Myeloma Patients
Phase 1/Phase 2 · Tom Baker Cancer Center/Alberta Health Services · Karyopharm Therapeutics Inc · NCT02343042 Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma
Phase 2 · Arthur J.E. Child Comprehensive Cancer Centre · Canadian Cancer Trials Group · NCT05998642 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Alberta Children's Hospital · Children's Oncology Group · NCT04322318

Look up another city

Look up another condition